MannKind Corp. (MNKD)
3.605
+0.08
(+2.12%)
USD |
NASDAQ |
May 27, 14:57
MannKind Cash from Investing (Quarterly) : 18.72M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| United Therapeutics Corp. | 743.70M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Insmed, Inc. | 265.52M |
| Agios Pharmaceuticals, Inc. | 141.31M |
| ADMA Biologics, Inc. | 2.404M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.644M |
| Cash from Financing (Quarterly) | -35.13M |
| Free Cash Flow | 13.07M |
| Free Cash Flow Per Share (Quarterly) | -0.0244 |
| Free Cash Flow to Equity (Quarterly) | 29.18M |
| Free Cash Flow to Firm (Quarterly) | 5.102M |
| Free Cash Flow Yield | 1.17% |